Elevated expression of MRP3 in GBM patient specimens, strong GST-π protein expression in human gliomas [61], a functional polymorphism in EGF [62], and high GPNMB expression in GBM patients [9] are associated with clinically more aggressive gliomas and are useful and powerful prognostic markers of poor patient survival. Here, EGF is linked to central nervous system cancer.